Kymera
oral agent with potential to achieve broad well tolerated anti inflammatory effect in multiple diseases | Kymera
Company
Deck Type
Sector
Industry
Deck date
November 2023
Slide
19 of 41
Similar slides by Kymera
See diffirences between slides (animation)
Investor Presentation
December 2023
oral agent with potential to achieve broad well tolerated anti inflammatory effect in multiple diseases | Kymera
Related slides by other companies
argenx SE
Investor Conference
January 2023
musk agonist with broad potential in neuromuscular disease | argenx SE
argenx SE
Investor Presentation
June 2023
musk agonist with broad potential in neuromuscular disease | argenx SE
argenx SE
Investor Presentation
November 2023
musk agonist with broad potential in neuromuscular disease clinical | argenx SE
Ocuphire Pharma
Investor Day
January 2022
broad opportunities to treat retinal diseases with platform treatments proven novel mechanism as | Ocuphire Pharma
Other recent decks by Kymera
See all presentations (7 decks)
Investor Presentation
December 2023
Investor Presentation
August 2023
Investor Presentation
June 2023
Results
December 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io